ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EDEN Eden Research Plc

4.35
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.35 4.20 4.50 4.35 4.35 4.35 0.00 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.36 23.2M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.35p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 7.625p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.20 million. Eden Research has a price to earnings ratio (PE ratio) of -10.36.

Eden Research Share Discussion Threads

Showing 14151 to 14169 of 18550 messages
Chat Pages: Latest  574  573  572  571  570  569  568  567  566  565  564  563  Older
DateSubjectAuthorDiscuss
01/2/2023
17:05
I've invested in lots of different stocks over a long period of time. Whatever you think I am, I am not. I have one profile, and I'm the only person to post on it.Regarding EDEN, it may go to zero it may go to all-time highs.... only time will tell..... my position remains the same, and I won't buy or sell a share until the funding issue is clear. You on the other hand Neyt
timbo_slice
01/2/2023
16:20
Tom, and I can speak with certainty about him, does not hate what you think he does. Like me, he hates people being swindled. As happens here.

As to you, you and three of your socks/dupes write in exactly the same passive-resistant style, and using external search on ADVFN posts by you and one of them (isn't g00gle wonderful?) shows that both are/were interested in or have apparently invested in the same three preposterous AIM stocks, two of them already flatlined and extinct:
SNRP
XEL
EDEN
Simple as that. Proving you're stupid, to tell lies so easily refuted and which may/should count against you in court when this all goes pear-shaped.

Great fun! ;D

neutralpov
01/2/2023
13:45
If you're wrong about me (which you are), I think you may be wrong about EDEN. You have no credibility, which is a shame as you seem well-intentioned.
timbo_slice
31/1/2023
19:53
I'm not sure there is such a thing as a related party sale. Tom W. Is an interesting character, and I wish him all the best... he does seem to hate EDEN.....And Neuts, you're getting boring... I have one ID, and I'm the only person who uses it.
timbo_slice
31/1/2023
19:39
JakNife..the deleter extraordinaire who I kid you not could not say 'Cedroz' and who predicted 2p by Xmas17 asks us to take note of the guy who missed the biggest fraud in history.

With that track record I think I'll pass.


LOL

supersonico
31/1/2023
18:27
Friends, let's find common ground. 0:-)

Apart from lying fraudster rampers like Timbo_Slice+28_Other_Dupe_IDs, and mad gender-confused supersonico, we all agree that anyone who, despite the FRC investigation and upholding of the serious complaint, places any reliance whatsoever on any claim made by EDEN must be seriously deficient in the Mental Department, and need medication for sure, incarceration probably, maybe a straitjacket too.

Next!!

neutralpov
31/1/2023
12:21
Neuts, you are the only troll here.
timbo_slice
31/1/2023
10:19
Ask under the bridge, where the other trolls reside, you impudent 'wipe.
neutralpov
31/1/2023
07:55
Do boiler rooms still exist?
timbo_slice
31/1/2023
02:10
Ask around in the boiler room.....
neutralpov
30/1/2023
13:22
Are paid rampers and shortsellers an actual thing?
timbo_slice
30/1/2023
12:35
Where's all this deceitful positive spin coming from?

Answer for Brucie5

Lying multi-avatars (who knows how many duplicate sock-puppet accounts with ADVFN?) who are either up to their eyeballs in this diseased dawg of AIM and desperately looking for an upward bump so they can offload, or are actually PAID RAMPERS (i.e., criminals operating in breach of FSMA2000 and who should be imprisoned or worse).

neutralpov
30/1/2023
12:03
Good post, Super, thanks. It's difficult to rediscover my former confidence in the business model, though the chart may now be trying to consolidate over 5p and as such, tell a different story. Non-chemical insecticide would of course be huge, if successful and from memory, potentially dwarf the others? Maybe time to dust down my notes.
Hopefully Jak will appear shortly to put us all on our mettle. I've noticed that he usually forewarns of his interest with a simple dot (.) after his byline, like a spot of botrytis on clean leaf.

So two things for experts here to have ready: when will sales begin in earnest? And what need for extra cash?
;)

brucie5
30/1/2023
11:46
Top up before it's too late!

Fill yer boots!!

CHEAPER than Chips!!!

Clear prospects of a return to £17 SP!

(chuckle)

This Moron-Magnet of a share ticks on, 11.59pm on the Doomsday Clock.

neutralpov
30/1/2023
07:07
First Mevalone authorisation for domestic use.
supersonico
30/1/2023
02:00
So, even using only the selection BY RAMPERS of unaudited fantasies this pariah of AIM has ejaculated over the years, it's clear it is going in crop circles, round and round, getting nowhere, just spouting noise and verbiage.
neutralpov
28/1/2023
14:51
Interesting progression of development/work.

The Company has now agreed on a final formulation.

I wonder if the final formulation was agreed with ALL of the potential partners who tested the several candidate insecticide products? Also, how much of the world do these partners cover sales wise, and whether their territories overlap.

weyweyumfozo
28/1/2023
13:47
Annual Insecticide / development update...2019-2023

15 January 2019;
The opportunities in Eden's core crop protection business are growing well. In addition to the products that Eden has developed and is commercialising through its partners, there are a number of pipeline products which are in the process of being tested by potential partners including several candidate insecticide products which would represent our first entry into the insecticide segment. Whilst it is early in the development of these formulations, initial results have been encouraging.


14 January 2020
Looking forward, we expect to be able to announce further marketing authorisations for both Mevalone and Cedroz as well as progress that is being made with existing and new partners in areas such as seed treatments, insecticides and other applications where the use of our active ingredients and Sustaineä encapsulation technology can bring important benefits to our commercial partners, growers, and ultimately consumers who benefit from sustainable agriculture."

11 February 2021
Development work continued largely as hoped during 2020, including on Eden's insecticide and seed treatment products. In addition, the Company continues to work with a number of parties to develop products that avoid polymer encapsulation using Eden's proprietary Sustaine® technology with third party active ingredients.

2nd March 2022
Development of Eden's seed treatment and insecticide products continues on track with good progress made in 2021 and the Corteva partnership has moved into the next stage of development triggering a milestone payment to Eden.


10 January 2023
Field trials in 2021 and 2022 have produced encouraging results for our insecticide candidates. The Company is pleased to be in position where it has now agreed on a final formulation, entered into testing agreements and sent trial-scale samples to multiple interested parties who are undertaking their own trial work.

Eden has started to see results from its potential partners come in and we are pleased to say that they are, thus far, in line with our own results.
The Company expects there to be a high level of interest for this product, particularly in the key markets of Europe and the US.

supersonico
28/1/2023
09:57
Hope springs eternal in the human breast:Man never is, but always to be blest.The soul, uneasy and confined from home,Rests and expatiates in a life to come.Or.......Rice, Rice, baby.
timbo_slice
Chat Pages: Latest  574  573  572  571  570  569  568  567  566  565  564  563  Older

Your Recent History

Delayed Upgrade Clock